Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients.
BACKGROUND: Fibroblast growth factor 23 (FGF23), with its co-receptor Klotho, plays a crucial role in phosphate metabolism. Several recent studies suggested that circulating FGF23 and α-Klotho concentrations might be related to cardiovascular abnormalities in patients with advanced renal failure. PU...
Main Authors: | Kensaku Shibata, Shu-Ichi Fujita, Hideaki Morita, Yusuke Okamoto, Koichi Sohmiya, Masaaki Hoshiga, Nobukazu Ishizaka |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3767778?pdf=render |
Similar Items
-
Correction: Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
by: Kensaku Shibata, et al.
Published: (2013-01-01) -
Correction: Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients.
by: Kensaku Shibata, et al.
Published: (2013-01-01) -
Serum uric acid is associated with left ventricular hypertrophy independent of serum parathyroid hormone in male cardiac patients.
by: Shu-ichi Fujita, et al.
Published: (2013-01-01) -
Correction: Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
by: The Staff
Published: (2014-01-01) -
Correction: Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients.
Published: (2014-01-01)